Accessibility Menu
TerrAscend logo

TerrAscend(OTC) TRSSF

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-48%
5 Year-91%
1 Year-36%
1 Month+16%
N/A
TerrAscend last closing stock price
MetricPriceDate
Last closeUSD 0.632026-08-21
TerrAscend stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.17%USD 0.582026-08-14
1 month+16.42%USD 0.542026-07-22
3 month-2.82%USD 0.652026-05-22
Year to date-12.26%USD 0.722025-12-31
1 year-36.19%USD 0.992025-08-21
3 year-63.27%USD 1.722023-08-22
5 year-91.14%USD 7.132021-08-20
Since inception-47.79%USD 1.212017-05-03

TerrAscend Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$270.60M

Net Income (TTM)

-$35.71M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 9, 2023

TRSSF News

growgeneration

Which Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?

James HalleyOct 19, 2023
A person inspect a cannabis plant with a magnifying glass.

This Will Be a Big Test for the Cannabis Industry

David Jagielski, CPAMar 29, 2023

TerrAscend Turns Its First Profit as Revenues Rise

Lukas BarfieldJul 10, 2022
People agreeing on a deal

This Upcoming Marijuana Merger Could Generate Great Returns for Investors

David Jagielski, CPASep 16, 2021
Young lady holding marijuana leaf in a field of plants

These Canadian Cannabis Producers May Benefit From an Israeli Medical Innovation

Jeffrey LittleMay 31, 2021
woman-holds-cannabis-dispensary

These 2 Under-the-Radar Cannabis Companies Are the Most Profitable in the Industry

Billy DubersteinMay 24, 2021
GettyImages-586206904

TerrAscend Acquiring 3 Pennsylvania Marijuana Dispensaries for $63 Million

Eric VolkmanApr 22, 2021
GettyImages-1189095592

5 Pot Stocks Making Big Moves on the 50th Anniversary of 4/20

Billy DubersteinApr 20, 2021
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TerrAscend

TerrAscend Corp. operates as a cannabis enterprise, focusing on the cultivation, production, and distribution of various cannabis products across Canada and the United States. The company offers a diverse range of products, including vaporizable items, concentrates, topicals, and edibles, catering to both medical and recreational consumers.

Products and Services
  • Vaporizable products and concentrates
  • Topicals, dried flower, tinctures, and edibles
  • Retail dispensaries under multiple brand names
Growth Outlook
  • Revenue of $65.4 million in Q2 2026, showing consistent demand
  • Gross profit margin of 52.1% in Q2 2026, indicating strong operational efficiency
  • Expansion into new markets expected to drive future growth
Financial Highlights
  • Net income of -$8.9 million in Q2 2026, reflecting ongoing investment in growth
  • Operating income of $11.8 million in Q2 2026, showcasing operational strength
  • Current ratio of 1.83, indicating solid liquidity position
TerrAscend Corp. has established itself as a significant player in the cannabis industry, with a comprehensive product portfolio and a focus on both medical and recreational markets. The company's recent financial performance highlights a strong revenue base and operational efficiency, despite facing challenges in net income. The growth outlook remains positive, driven by market expansion and a commitment to innovation. Investors may find the company's strategic positioning and financial metrics indicative of potential long-term value in the evolving cannabis landscape.
AI Generated • Aug 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,038

CEO

Ziad Ghanem, PharmD

Website

www.terrascend.com

Headquarters

Mississauga, ON L5B 4A7, CA

TRSSF Financials

Key Financial Metrics (TTM)

Gross Margin

51.16%

Operating Margin

17.05%

Net Income Margin

-15.67%

Return on Equity

-45.81%

Return on Capital

28.72%

Return on Assets

-7.43%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$137.14M

Operating Income

$38.86M

EBITDA

$10.16M

Operating Cash Flow

$31.48M

Capital Expenditure

$0.00

Free Cash Flow

$31.48M

Cash & ST Invst.

$42.03M

Total Debt

$46.34M

TerrAscend Performance Analysis

TerrAscend annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 247,829,00027.6%
20232023-12-31USD 317,328,00028.0%
20242024-12-31USD 268,078,000-15.5%
20252025-12-31USD 260,558,000-2.8%
TerrAscend sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-300.1%
Q42025-12-3111.9%
Q12026-03-31-10.0%
Q22026-06-302.4%
TerrAscend annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.35N/A
20232023-12-31USD -0.34-74.7%
20242024-12-31USD -0.28-19.6%
20252025-12-31USD -0.294.1%
TerrAscend sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-166.7%
Q42025-12-31112.5%
Q12026-03-31-400.0%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$67.12M

+3.3%

Gross Profit

$36.25M

+9.1%

Gross Margin

54.01%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

972

N/A

Net Income

-$8.06M

+83.7%

EBITDA

$4.82M

-65.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$42.03M

+51.9%

Total Debt

$46.34M

-80.9%

Accounts Receivable

$16.32M

-11.4%

Inventory

$39.18M

+10.6%

Long Term Debt

$45.22M

-80.4%

Short Term Debt

$1.12M

-90.7%

Return on Assets

-7.43%

N/A

Return on Invested Capital

9.11%

N/A

Free Cash Flow

$7.39M

+1081.6%

Operating Cash Flow

$7.39M

+162.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CCHWFColumbia Care Inc.
$0.94-21.71%
CLAZFClaritas Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$120.60-0.01%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$47.03+0.02%
IBITiShares Bitcoin Trust
$43.68+0.06%
MSTRStrategy
$119.25+0.06%

Questions About TRSSF

What is the current price of TerrAscend?

TerrAscend is trading at N/A per share.

What is the 52-week range for TerrAscend?

Over the past 52 weeks, TerrAscend has traded between N/A and N/A.

How much debt does TerrAscend have?

As of the most recent reporting period, TerrAscend reported total debt of $243.61M.

How much cash does TerrAscend have on hand?

TerrAscend reported $42.03M in cash and cash equivalents in its most recent financial results.

What is TerrAscend’s dividend yield?

TerrAscend does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services